Pharmacovigilance, cosmetovigilance, hemovigilance, and materiovigilance in healthcare domains

Sachdev Yadav , Mansi Sinha , Kanishka Taradia , Anuj Kumar Sharma , Mayank Kulshreshtha
{"title":"Pharmacovigilance, cosmetovigilance, hemovigilance, and materiovigilance in healthcare domains","authors":"Sachdev Yadav ,&nbsp;Mansi Sinha ,&nbsp;Kanishka Taradia ,&nbsp;Anuj Kumar Sharma ,&nbsp;Mayank Kulshreshtha","doi":"10.1016/j.glmedi.2024.100175","DOIUrl":null,"url":null,"abstract":"<div><div>This commentary provides a comprehensive examination of four critical surveillance systems: pharmacovigilance, cosmetovigilance, hemovigilance, and Materiovigilance. It examines the surveillance systems used in each sector to ensure the safety of medicines, cosmetics, medical equipment, and blood products. The research emphasizes the significance of attentive monitoring to guarantee public health and safety, focusing on the distinct problems and regulatory frameworks connected with each vigilance sector. The synthesis of this comparative study helps to a thorough knowledge of the numerous tactics used to preserve health across different product categories. Pharmacovigilance is a crucial component of healthcare that focuses on monitoring and assessing the safety of pharmaceutical products. The evolving context of drug safety surveillance, regulatory frameworks, and the implementation of technology into pharmacovigilance methods are also discussed. Additionally, this commentary discusses the collaborative efforts among healthcare professionals, regulatory agencies, and pharmaceutical industries to ensure the ongoing safety of medications and improve patient outcomes. The other three essential components of healthcare safety- Hemovigilance, Cosmetovigilance, and Materiovigilance. Hemovigilance focuses on monitoring and ensuring the safety of blood and blood product transfusions. Cosmetovigilance involves the surveillance of adverse events related to cosmetic products, emphasizing consumer safety. Materiovigilance addresses the monitoring and management of incidents associated with medical devices, emphasizing their safety and performances. The outcome of this comparative commentary highlights both shared and different issues across various vigilance systems. Underreporting, data integration, and the need for strong regulatory frameworks are typical problems. The analysis offers a comprehensive picture of the vigilant environment by combining information from these four domains, encouraging a multidisciplinary approach to improving consumer product and healthcare safety.</div></div>","PeriodicalId":100804,"journal":{"name":"Journal of Medicine, Surgery, and Public Health","volume":"5 ","pages":"Article 100175"},"PeriodicalIF":0.0000,"publicationDate":"2024-12-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Medicine, Surgery, and Public Health","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2949916X24001282","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

This commentary provides a comprehensive examination of four critical surveillance systems: pharmacovigilance, cosmetovigilance, hemovigilance, and Materiovigilance. It examines the surveillance systems used in each sector to ensure the safety of medicines, cosmetics, medical equipment, and blood products. The research emphasizes the significance of attentive monitoring to guarantee public health and safety, focusing on the distinct problems and regulatory frameworks connected with each vigilance sector. The synthesis of this comparative study helps to a thorough knowledge of the numerous tactics used to preserve health across different product categories. Pharmacovigilance is a crucial component of healthcare that focuses on monitoring and assessing the safety of pharmaceutical products. The evolving context of drug safety surveillance, regulatory frameworks, and the implementation of technology into pharmacovigilance methods are also discussed. Additionally, this commentary discusses the collaborative efforts among healthcare professionals, regulatory agencies, and pharmaceutical industries to ensure the ongoing safety of medications and improve patient outcomes. The other three essential components of healthcare safety- Hemovigilance, Cosmetovigilance, and Materiovigilance. Hemovigilance focuses on monitoring and ensuring the safety of blood and blood product transfusions. Cosmetovigilance involves the surveillance of adverse events related to cosmetic products, emphasizing consumer safety. Materiovigilance addresses the monitoring and management of incidents associated with medical devices, emphasizing their safety and performances. The outcome of this comparative commentary highlights both shared and different issues across various vigilance systems. Underreporting, data integration, and the need for strong regulatory frameworks are typical problems. The analysis offers a comprehensive picture of the vigilant environment by combining information from these four domains, encouraging a multidisciplinary approach to improving consumer product and healthcare safety.
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信